These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36063974)

  • 1. Botulinum toxin A (BoNT/A) for the treatment of depression: A randomized, double-blind, placebo, controlled trial in China.
    Li Y; Zhu T; Shen T; Wu W; Cao J; Sun J; Liu J; Zhou X; Jiang C; Tang Z; Liu T; Chen L; Hu H; Luo W
    J Affect Disord; 2022 Dec; 318():48-53. PubMed ID: 36063974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and efficacy of botulinum toxin A on the treatment of depression.
    Zhang Q; Wu W; Fan Y; Li Y; Liu J; Xu Y; Jiang C; Tang Z; Cao C; Liu T; Chen LH; Hu H; Luo W
    Brain Behav; 2021 Sep; 11(9):e2333. PubMed ID: 34423572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of escitalopram combined with botulinum toxin A in patients with generalized anxiety disorder and comorbid headache.
    Wang Y; Yang X; Ji X; Liu M; Zhou C
    Psychopharmacology (Berl); 2023 Oct; 240(10):2061-2070. PubMed ID: 37481677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facing depression with botulinum toxin: a randomized controlled trial.
    Wollmer MA; de Boer C; Kalak N; Beck J; Götz T; Schmidt T; Hodzic M; Bayer U; Kollmann T; Kollewe K; Sönmez D; Duntsch K; Haug MD; Schedlowski M; Hatzinger M; Dressler D; Brand S; Holsboer-Trachsler E; Kruger TH
    J Psychiatr Res; 2012 May; 46(5):574-81. PubMed ID: 22364892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C;
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Toxin Type A for the Treatment of Post-traumatic Headache: A Randomized, Placebo-Controlled, Cross-over Study.
    Zirovich MD; Pangarkar SS; Manh C; Chen L; Vangala S; Elashoff DA; Izuchukwu IS
    Mil Med; 2021 May; 186(5-6):493-499. PubMed ID: 33241323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to treating post-stroke depression: administration of Botulinum Toxin A via local facial injection.
    Feng XY; Shen TT; Wu QC; Wang J; Ni P; Liu J; Zhou XP; Hu H; Luo WF
    Front Neurol; 2024; 15():1372547. PubMed ID: 38957350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
    Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study.
    Kongsaengdao S; Arayawithchanont A; Samintharapanya K; Rojanapitayakorn P; Maneeton B; Maneeton N
    Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34678987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
    Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study.
    Magid M; Reichenberg JS; Poth PE; Robertson HT; LaViolette AK; Kruger TH; Wollmer MA
    J Clin Psychiatry; 2014 Aug; 75(8):837-44. PubMed ID: 24910934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is botulinum toxin A effective for the treatment of plantar fasciitis?
    Peterlein CD; Funk JF; Hölscher A; Schuh A; Placzek R
    Clin J Pain; 2012 Jul; 28(6):527-33. PubMed ID: 22673486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study.
    Ondo WG; Simmons JH; Shahid MH; Hashem V; Hunter C; Jankovic J
    Neurology; 2018 Feb; 90(7):e559-e564. PubMed ID: 29343468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor: A Randomized Clinical Trial.
    Rajan R; Srivastava AK; Anandapadmanabhan R; Saini A; Upadhyay A; Gupta A; Vishnu VY; Pandit AK; Vibha D; Singh MB; Bhatia R; Goyal V; Dwivedi SN; Srivastava P; Prasad K
    JAMA Neurol; 2021 Mar; 78(3):302-311. PubMed ID: 33346814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-Guided BoNT-A (Botulinum Toxin A) Injection Into the Subscapularis for Hemiplegic Shoulder Pain: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Tan B; Jia L
    Stroke; 2021 Dec; 52(12):3759-3767. PubMed ID: 34470492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early botulinum toxin treatment for spastic pes equinovarus--a randomized double-blind placebo-controlled study.
    Fietzek UM; Kossmehl P; Schelosky L; Ebersbach G; Wissel J
    Eur J Neurol; 2014 Aug; 21(8):1089-1095. PubMed ID: 24754350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
    Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.